@article{APS10523,
author = {Rui Tang and Qian-qian Cao and Sheng-wei Hu and Lu-juan He and Peng-fei Du and Gang Chen and Rao Fu and Fei Xiao and Yi-rong Sun and Ji-chun Zhang and Qi Qi},
title = {Sulforaphane activates anti-inflammatory microglia, modulating stress resilience associated with BDNF transcription},
journal = {Acta Pharmacologica Sinica},
volume = {43},
number = {4},
year = {2022},
keywords = {},
abstract = {Sulforaphane (SFN) is an organic isothiocyanate and an NF-E2-related factor-2 (Nrf2) inducer that exerts prophylactic effects on depression-like behavior in mice. However, the underlying mechanisms remain poorly understood. Brain-derived neurotrophic factor (BDNF), a neurotrophin, is widely accepted for its antidepressant effects and role in stress resilience. Here, we show that SFN confers stress resilience via BDNF upregulation and changes in abnormal dendritic spine morphology in stressed mice, which is accompanied by rectifying the irregular levels of inflammatory cytokines. Mechanistic studies demonstrated that SFN activated Nrf2 to promote BDNF transcription by binding to the exon I promoter, which is associated with increased Nrf2, and decreased methyl- CpG binding protein-2 (MeCP2), a transcriptional suppressor of BDNF, in BV2 microglial cells. Furthermore, SFN inhibited the pro- inflammatory phenotype and activated the anti-inflammatory phenotype of microglia, which was associated with increased Nrf2 and decreased MeCP2 expression in microglia of stressed mice. Hence, our findings support that Nrf2 induces BDNF transcription via upregulation of Nrf2 and downregulation of MeCP2 in microglia, which is associated with changes in the morphology of damaged dendritic spines in stressed mice. Meanwhile, the data presented here provide evidence for the application of SFN as a candidate for the prevention and intervention of depression.},
issn = {1745-7254}, url = {http://www.chinaphar.com/article/view/10523}
}